+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Transplantation Market Report and Forecast 2023-2031

  • PDF Icon

    Report

  • 147 Pages
  • April 2023
  • Region: Global
  • Expert Market Research
  • ID: 5780703
The global transplantation market size reached a value of USD 13.8 billion in 2022. The market is likely to grow at a rate of 9.4% in the forecast period of 2023-2031 to reach a market value of USD 31.5 billion by 2031. The increasing research and developmental activities, along with technological advancements are supporting the market growth.

Transplantation Market: Introduction

The global transplantation market refers to the market for organ transplantation, which involves the surgical removal of organs or tissues from one person (the donor) and transplanting them into another person (the recipient). The transplantation market is driven by factors such as the increasing prevalence of chronic diseases leading to organ failure, advancements in surgical techniques, and the growing demand for transplantation procedures.

Transplantation - Application and Usage

Transplantation is primarily used for the treatment of end-stage organ failure or tissue damage caused by a variety of chronic diseases. The transplantation procedures involve removing a diseased or damaged organ or tissue from the recipient and transplanting a healthy organ or tissue from a donor. The most common types of transplantation procedures include:
1. Organ Transplantation: This involves the transplantation of organs such as the kidney, liver, lung, heart, pancreas, and small intestine. Organ transplantation is often used to treat end-stage organ failure caused by chronic diseases such as diabetes, heart disease, and kidney disease. The most common type of organ transplantation is kidney transplantation.
2. Tissue Transplantation: This involves the transplantation of tissues such as skin, bone, cornea, heart valves, and veins. Tissue transplantation is often used to treat burns, injuries, and other types of tissue damage.
3. Stem Cell Transplantation: This involves the transplantation of stem cells to replace damaged or diseased cells in the body. Stem cell transplantation is often used to treat blood cancers such as leukaemia and lymphoma.

Transplantation procedures are typically performed in specialized transplant centres and require a highly skilled team of surgeons, nurses, and other medical professionals. The success of a transplantation procedure depends on a variety of factors, including the compatibility of the donor and recipient, the quality of the organ or tissue, and the skill of the surgical team.

While transplantation procedures offer a potentially life-saving treatment option for patients with end-stage organ failure or tissue damage, they also carry significant risks. These risks include the risk of organ rejection, infection, and complications from immunosuppressive drugs used to prevent organ rejection.

Transplantation Market Segmentations

The market can be categorised into product, type of transplant, application, end user, and major regions.

Market Breakup by Product

  • Transplant Preservative Solutions
  • Transplant Diagnostics
  • Tissue Products
  • Immunosuppressive Drugs
  • Others

Market Breakup by Type of Transplant

Solid Organ Transplant

  • Kidney
  • Heart
  • Lungs
  • Liver
  • Intestine
  • Others

Stem Cell Transplant

  • Autologous Transplants
  • Allogenic Transplants

Tissue Transplant

  • Autografts
  • Allografts
  • Others

Transplantation Market Breakup by Application

  • Clinical Therapeutics
  • Translational Research
  • Diagnostic Purposes
  • Others

Market Breakup by End User

  • Hospitals
  • Transplantation Centres
  • Others

Transplantation Market Breakup by Region

North America

  • United States of America
  • Canada

Europe

  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Transplantation Market Scenario

The transplantation market is being driven by factors such as the increasing prevalence of chronic diseases leading to organ failure, advancements in surgical techniques, and the growing demand for transplantation procedures. North America dominated the global transplantation market in 2020, followed by Europe and the Asia Pacific. The high prevalence of chronic diseases such as diabetes, favorable reimbursement policies, and the presence of many key players in the region are driving the growth of the market in North America and Europe.

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic diseases leading to organ failure, rising healthcare expenditure in the region, and the growing demand for transplantation procedures. Moreover, the increasing investments in healthcare infrastructure and research and development activities are expected to fuel the growth of the transplantation market in the Asia Pacific region.

Key Players in the Global Transplantation Market

The report gives an in-depth analysis of the key players involved in the transplantation market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • AbbVie Inc
  • Arthrex, Inc
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLife Solutions
  • Teva Pharmaceutical Industries Ltd
  • Astellas Pharma Inc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
2 Research Methodology3 Executive Summary
4 Transplantation Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Treatment Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Treatment Success Rate
6 Current Scenario Evaluation and Regulatory Framework
6.1 Emerging Therapies and Clinical Trials
6.2 Patent Landscape
6.2.1 Patent Overview
6.2.1.1 Patent Status and Expiry
6.2.1.2 Timelines from Drug Development to Commercial Launch
6.2.1.3 New Drug Application
6.2.1.3.1 Documentation and Approval Process
6.3 Cost of Treatment
6.4 Regulatory Framework
6.4.1 Regulatory Overview
6.4.1.1 US FDA
6.4.1.2 EU EMA
6.4.1.3 INDIA CDSCO
6.4.1.4 JAPAN PMDA
6.4.1.5 Others
7 Challenges and Unmet Needs
7.1 Treatment Pathway Challenges
7.2 Compliance and Drop-Out Analysis
7.3 Awareness and Prevention Gaps
8 Global Transplantation Market
8.1 Global Transplantation Market Overview
8.2 Global Transplantation Market Analysis
8.2.1 Market Overview
8.2.1.1 Global Transplantation Market Historical Value (2016-2022)
8.2.1.2 Global Transplantation Market Forecast Value (2023-2031)
8.2.2 Global Transplantation Market by Category of Product
8.2.2.1 Market Overview
8.2.2.1.1 Transplant Preservative Solutions
8.2.2.1.2 Transplant Diagnostics
8.2.2.1.3 Tissue Products
8.2.2.1.4 Immunosuppressive Drugs
8.2.2.1.5 Others
8.2.3 Global Transplantation Market by Type of Transplant
8.2.3.1 Market Overview
8.2.3.1.1 Solid Organ Transplant
8.2.3.1.1.1 Kidney
8.2.3.1.1.2 Heart
8.2.3.1.1.3 Lungs
8.2.3.1.1.4 Liver
8.2.3.1.1.5 Intestine
8.2.3.1.1.6 Others
8.2.3.1.2 Stem Cell Transplant
8.2.3.1.2.1 Autologous Transplants
8.2.3.1.2.2 Allogenic Transplants
8.2.3.1.3 Tissue Transplant
8.2.3.1.3.1 Autografts
8.2.3.1.3.2 Allografts
8.2.3.1.4 Others
8.2.4 Global Transplantation Market by Application
8.2.4.1 Market Overview
8.2.4.1.1 Clinical Therapeutics
8.2.4.1.2 Translational Research
8.2.4.1.3 Diagnostic Purposes
8.2.4.1.4 Others
8.2.5 Global Transplantation Market by End-User
8.2.5.1 Market Overview
8.2.5.1.1 Hospitals
8.2.5.1.2 Transplantation Centres
8.2.5.1.3 Others
8.2.6 Global Transplantation Market by Region
8.2.6.1 Market Overview
8.2.6.1.1 North America
8.2.6.1.2 Europe
8.2.6.1.3 Asia Pacific
8.2.6.1.4 Middle East and Africa
8.2.6.1.5 Latin America
9 North America Transplantation Treatment Market
9.1 Market Share by Country
9.2 United States of America
9.2.1 Historical Trend (2016-2022)
9.2.2 Forecast Trend (2023-2031)
9.3 Canada
9.3.1 Historical Trend (2016-2022)
9.3.2 Forecast Trend (2023-2031)
10 Europe Transplantation Treatment Market
10.1 Market Share by Country
10.2 United Kingdom
10.2.1 Historical Trend (2016-2022)
10.2.2 Forecast Trend (2023-2031)
10.3 Germany
10.3.1 Historical Trend (2016-2022)
10.3.2 Forecast Trend (2023-2031)
10.4 France
10.4.1 Historical Trend (2016-2022)
10.4.2 Forecast Trend (2023-2031)
10.5 Italy
10.5.1 Historical Trend (2016-2022)
10.5.2 Forecast Trend (2023-2031)
10.6 Others
11 Asia Pacific Transplantation Treatment Market
11.1 Market Share by Country
11.2 China
11.2.1 Historical Trend (2016-2022)
11.2.2 Forecast Trend (2023-2031)
11.3 Japan
11.3.1 Historical Trend (2016-2022)
11.3.2 Forecast Trend (2023-2031)
11.4 India
11.4.1 Historical Trend (2016-2022)
11.4.2 Forecast Trend (2023-2031)
11.5 ASEAN
11.5.1 Historical Trend (2016-2022)
11.5.2 Forecast Trend (2023-2031)
11.6 Australia
11.6.1 Historical Trend (2016-2022)
11.6.2 Forecast Trend (2023-2031)
11.7 Others
12 Latin America Transplantation Treatment Market
12.1 Market Share by Country
12.2 Brazil
12.2.1 Historical Trend (2016-2022)
12.2.2 Forecast Trend (2023-2031)
12.3 Argentina
12.3.1 Historical Trend (2016-2022)
12.3.2 Forecast Trend (2023-2031)
12.4 Mexico
12.4.1 Historical Trend (2016-2022)
12.4.2 Forecast Trend (2023-2031)
12.5 Others
13 Middle East and Africa Transplantation Treatment Market
13.1 Market Share by Country
13.2 Saudi Arabia
13.2.1 Historical Trend (2016-2022)
13.2.2 Forecast Trend (2023-2031)
13.3 United Arab Emirates
13.3.1 Historical Trend (2016-2022)
13.3.2 Forecast Trend (2023-2031)
13.4 Nigeria
13.4.1 Historical Trend (2016-2022)
13.4.2 Forecast Trend (2023-2031)
13.5 South Africa
13.5.1 Historical Trend (2016-2022)
13.5.2 Forecast Trend (2023-2031)
13.6 Others
14 Global Transplantation Market Dynamics
14.1 Market Drivers and Constraints
14.2 SWOT Analysis
14.3 Porter’s Five Forces Model
14.4 Key Demand Indicators
14.5 Key Price Indicators
14.6 Industry Events, Initiatives, and Trends
14.7 Value Chain Analysis
15 Supplier Landscape
15.1 AbbVie Inc.
15.1.1 Company Overview
15.1.2 Product Portfolio
15.1.3 Demographic Reach and Achievements
15.1.4 Mergers and Acquisitions
15.1.5 Certifications
15.2 Arthrex, Inc.
15.2.1 Company Overview
15.2.2 Product Portfolio
15.2.3 Demographic Reach and Achievements
15.2.4 Mergers and Acquisitions
15.2.5 Certifications
15.3 Zimmer Biomet
15.3.1 Company Overview
15.3.2 Product Portfolio
15.3.3 Demographic Reach and Achievements
15.3.4 Mergers and Acquisitions
15.3.5 Certifications
15.4 Medtronic
15.4.1 Company Overview
15.4.2 Product Portfolio
15.4.3 Demographic Reach and Achievements
15.4.4 Mergers and Acquisitions
15.4.5 Certifications
15.5 Novartis AG
15.5.1 Company Overview
15.5.2 Product Portfolio
15.5.3 Demographic Reach and Achievements
15.5.4 Mergers and Acquisitions
15.5.5 Certifications
15.6 Stryker
15.6.1 Company Overview
15.6.2 Product Portfolio
15.6.3 Demographic Reach and Achievements
15.6.4 Mergers and Acquisitions
15.6.5 Certifications
15.7 21st Century Medicine
15.7.1 Company Overview
15.7.2 Product Portfolio
15.7.3 Demographic Reach and Achievements
15.7.4 Mergers and Acquisitions
15.7.5 Certifications
15.8 BioLife Solutions
15.8.1 Company Overview
15.8.2 Product Portfolio
15.8.3 Demographic Reach and Achievements
15.8.4 Mergers and Acquisitions
15.8.5 Certifications
15.9 Teva Pharmaceutical Industries Ltd.
15.9.1 Company Overview
15.9.2 Product Portfolio
15.9.3 Demographic Reach and Achievements
15.9.4 Mergers and Acquisitions
15.9.5 Certifications
15.10 Astellas Pharma Inc.
15.10.1 Company Overview
15.10.2 Product Portfolio
15.10.3 Demographic Reach and Achievements
15.10.4 Mergers and Acquisitions
15.10.5 Certifications
16 Global Transplantation Market- Distribution Model (Additional Insight)
16.1 Overview
16.2 Potential Distributors
16.3 Key Parameters for Distribution Partner Assessment
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket

Companies Mentioned

  • AbbVie Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLife Solutions
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.

Methodology

Loading
LOADING...

Table Information